Medicine and Dentistry
3 Hydroxybutyric Acid
36%
Acetic Acid
7%
Advance Care Planning
9%
Aortic Valve Stenosis
9%
Blood Flow
14%
Carbon 11
10%
Carbon 13
21%
Cardiac Magnetic Resonance Imaging
11%
Cardiogenic Shock
23%
Cardiovascular Effect
19%
Cardiovascular System
10%
Congestive Heart Failure
11%
Continuous Positive Airway Pressure
9%
Diabetes
20%
Diabetes Mellitus
8%
Disease
10%
Echocardiography
17%
Ejection Fraction
17%
Exercise Test
14%
Fatty Acid
13%
Glucose Uptake
24%
Glycon
9%
Heart Failure
100%
Heart Failure with Reduced Ejection Fraction
17%
Heart Function
7%
Heart Left Ventricle Ejection Fraction
22%
Heart Left Ventricle Function
11%
Heart Muscle Blood Flow
12%
Heart Muscle Metabolism
13%
Heart Muscle Oxygen Consumption
19%
Heart Output
33%
Hemodynamic
33%
Infective Endocarditis
12%
Infusion
16%
Ischemic Cardiomyopathy
11%
Ketone Bodies
37%
Lactic Acid
10%
Liraglutide
14%
Magnetic Resonance Imaging
10%
Maturity Onset Diabetes of the Young
13%
Metabolite
7%
Myocardium
20%
Patient with Type 2 Diabetes
15%
Placebo
32%
Positron Emission Tomography
28%
Proteomics
9%
Pyruvic Acid
20%
Radioactive Tracer
7%
Stroke Volume
10%
Symptom
9%
Pharmacology, Toxicology and Pharmaceutical Science
1,3 Butanediol
5%
3 Hydroxybutyric Acid
30%
All Cause Mortality
8%
Bacterial Endocarditis
11%
Beta Adrenergic Receptor Blocking Agent
9%
Carbon 11
8%
Carbon 13
10%
Cohort Study
7%
Combination Therapy
5%
Diabetes Mellitus
6%
Fatty Acid
14%
Glucagon Like Peptide 1 Receptor Agonist
5%
Heart Failure
88%
Heart Failure with Reduced Ejection Fraction
11%
Heart Muscle Ischemia
9%
Ischemia
7%
Ischemic Cardiomyopathy
6%
Ketone Bodies
31%
Liraglutide
18%
Non Insulin Dependent Diabetes Mellitus
17%
Normal Human
7%
Placebo
24%
Pyruvic Acid
14%
Systolic Heart Failure
5%
Tracer
6%
Keyphrases
3-hydroxybutyrate
8%
Cardiac Output
9%
Cardiovascular Effects
14%
Chronic Heart Failure
5%
Glucagon-like
5%
Heart Failure Patients
7%
Heart Failure with Preserved Ejection Fraction (HFpEF)
9%
Ketone Bodies
9%
Left Ventricular Ejection Fraction
7%
Patients with Heart Failure
14%